Transferring a biologic candidate from the research and development phase to commercial production usually requires increasing the working volume of the upstream bioprocess. During scale-up, process ...
GEN: Can you speak to your experiences with scale-down screening model systems? Do you have a preference? Sieck: The best screening model depends on specific needs. An ideal small-scale model should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback